MDNA-56

N/A

Report date: 2025/01/26 16:31:40

Base Information

Drug NameMDNA-56
Drug Alias NameMDNA-56
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionInterleukin-4 receptors inhibitors
TargetsInterleukin-4 receptors
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMedicenna Therapeutics Pte Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A